M
Med fusion
Biotech & Life Sciences · Lewisville, United States · Founded 2010
Helps the healthcare community redefine the delivery of clinical laboratory and trial services MoreLess
Med Fusion, acquired by Quest Diagnostics on July 21, 2017, operates as an integrated Molecular Center of Excellence and clinical trials organization. The company provides advanced laboratory diagnostics and comprehensive support services to healthcare providers and biotech pharmaceutical companies. Med Fusion's full-service clinical laboratory includes a dedicated team for test development and validation, as well as reference lab services such as pathology and molecular response testing.
Med Fusion serves a diverse range of clients, primarily focusing on healthcare providers and biotech firms that require precise and reliable diagnostic services. The company operates within the healthcare and biotechnology markets, leveraging its expertise to meet the specific needs of these sectors.
The business model of Med Fusion revolves around offering specialized diagnostic services and clinical trial support. Revenue is generated through service contracts with healthcare providers and biotech companies, who rely on Med Fusion's advanced laboratory capabilities to enhance patient care and accelerate drug development processes.
Keywords: molecular diagnostics, clinical trials, healthcare providers, biotech firms, test development, validation, pathology, molecular response, laboratory services, precision medicine.
Company overview
Med fusion company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2010
- Headquarters
- Lewisville, United States
- Employees
- 82
- Open positions
- None listed
- Dealroom signal
- 31.5
Valuation & funding
Med fusion funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jun 2017 | $0 | — | Quest Diagnostics | — |
| LATE VCOther financing | Jan 2014 | $61M | $245M | Undisclosed | — |
Growth signals
Med fusion website traffic
Latest recorded traffic for Med fusion is 3.9K monthly website visits, up 5.4% over the last three months. Med fusion's team declined 27.4% over the past year.
Comparisons
Med fusion compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Med fusion's talent
Source: Dealroom Talent Intelligence.
Investors
1 investor on Med fusion's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Med fusion has talent and traffic
team presence
In the news
Latest news about Med fusion
Recent press, funding announcements, and product moves mentioning Med fusion — open to read from the original sources.
Market sentiment
What the market is saying about Med fusion
An AI-synthesized read of the highest-engagement posts about Med fusion on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Med fusion’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.